| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.15 | 4e-05 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.14 | 5e-05 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0002 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.16 | 0.0002 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.19 | 0.0002 |